Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes
Wednesday 12 March 2025, 12:55 AM
14 minutes to Read
Douglas Pharmaceutical’s work in finding new uses for old drugs, plus developing generic drugs, will be boosted by a $35 million research and development facility. Fiona Cassie finds out more about the growing Douglas empire
Kia ora and welcome to Pharmacy Today Kaitiaki Rongoā O Te Wā
Not a subscriber? Unlock this article by subscribing here.